Seeking Alpha

Exclusive BAC Article: Lisata Therapeutics; Phase 2b ASCEND Data Release, Cohort B Data In 2025, Phase 3 Study Possible 2026 And Catalysts

I believe that a good speculative biotech to go over for the "Exclusive BAC Subscribers Article" would be Lisata Therapeutics (LSTA). The reason why I want to go over this biotech next is because it ...
Seeking Alpha

Exclusive BAC Article: Verve Therapeutics; Ph1b HEART-2 Study Data For HeFH 2nd Half 2025, Opt In Decision Eli Lilly For PCSK9 And Catalysts

I believe that a good speculative biotech to go over for the "Exclusive BAC Subscribers Article" would be Verve Therapeutics (VERV). The reason why I want to go over this biotech next is because just ...